Skip Navigation

National Award Recognizes Physiology Professor’s Research

NEWS
Mikhail Kellewan

National Award Recognizes Physiology Professor’s Research

March 22, 2024

NORMAN, OKLA. – Mikhail Kellawan, an associate professor in the Department of Health and Exercise Science and director of the Human Circulation Research Laboratory at the University of Oklahoma, has been awarded the John F. Perkins Jr. Research Career Enhancement Award from the American Physiological Society. This award allows early-career researchers to obtain special training or for an established researcher to develop new skills or retrain in areas of developing interest.

“My research focuses on studying how the body matches blood flow to the demands of tissue, specifically during exercise or environmental stress,” he said. “With this award, we will begin using microneurography to record nervous signals in humans. That’s important because the nervous system helps control blood pressure.”

According to Kellewan, his lab employs a wide array of techniques to measure blood flow during exercise. Adding microneurography will enhance their ability to learn how the cardiovascular system is controlled in humans.

“We use ultrasound to measure blood flow through a limb. At the same time, we’re employing a transcranial doppler to measure blood flow through the middle cerebral arteries. We also have many ways to measure the amount of oxygen consumed, carbon dioxide produced, heart rate, blood pressure and more,” he said. “However, the missing piece is the measurements of the sympathetic nervous system that the microneurography can produce. Once we have that, we’ll have a really advanced setup.”

While his lab already provides training for students interested in his research, adding this new technique will enhance their learning experiences and give them specialized knowledge that will likely help them in the future.

“Because we’re interested in measuring two circulations at the same time in the same person, our lab involves a lot of people. We currently have four doctoral students, two master’s students and another six or seven undergrads who volunteer with us,” he said. “With this new application, we’ll not only be able to capture new data sets, but we’ll be able to give our student researchers a more robust experience and make them more attractive candidates for faculty positions or fellowships in the future.”

Learn more about Kellawan’s research through the Human Circulation Research Lab and see the full list of award recipients from the American Physiological Society.

About the University of Oklahoma

Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. OU was named the state’s highest-ranking university in U.S. News & World Report’s most recent Best Colleges list. For more information about the university, visit ou.edu.


Recent News

April 12, 2024

Researchers Discover Cell ‘Crosstalk’ That Triggers Cancer Cachexia

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer. The research, led by Min Li, Ph.D., a professor in the OU College of Medicine, is published in the journal Cancer Cell.


April 11, 2024

OU Researcher Receives $3.1M Grant for Clean Hydrogen Technologies

Hanping Ding, Ph.D., an assistant professor in the School of Aerospace and Mechanical Engineering at the University of Oklahoma, has been awarded a $3.1 million grant from the Hydrogen and Fuel Cell Technologies Office in the Department of Energy through the Bipartisan Infrastructure Law to further research in clean hydrogen production. The funding is part of a $750 million effort in President Biden’s Investing in American agenda.


April 10, 2024

Genetic Testing May Provide Improved Medication Therapy Safety and Efficacy for Pediatric Cystic Fibrosis Patients

Second-year University of Oklahoma pediatric resident Dr. Caroline Thompson has a professional and personal connection to cystic fibrosis patient care for children. A childhood friend had the disease and made a lasting impression on Thompson. Now, Thompson has received the Cystic Fibrosis Foundation’s Medical Resident Research Award for a pilot study evaluating pharmacogenomic-directed therapy for pediatric patients at the Oklahoma Cystic Fibrosis Center Tulsa.